Analytical Data
-
基因名
CLSTN2
- Application
-
别名
CSTN2; CS2; CDHR13; Cadherin-Related Family Member 13; Alcadein-gamma
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9H4D0
-
表达区间
Arg31~Gln271
-
分子量
36kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CLSTN2, or calsyntenin-2, is a member of the calsyntenin family of proteins, which are implicated in various neurobiological processes, including synaptic transmission and neuronal differentiation. The interest in CLSTN2 has grown due to its potential role in neurodevelopmental disorders and neurodegenerative diseases. Research has suggested that CLSTN2 interacts with other key proteins involved in synapse formation and maintenance, thus influencing neuronal communication and plasticity. Additionally, variations in the CLSTN2 gene have been associated with conditions such as autism spectrum disorder, drawing attention to its significance in understanding the molecular underpinnings of these disorders. The development of recombinant CLSTN2 protein allows for the exploration of its structure-function relationships, facilitating studies on its biochemical properties and interactions within neuronal contexts. Overall, investigating CLSTN2 and its recombinant forms offers valuable insights into both its physiological roles in the nervous system and its potential implications in pathology, with prospects for therapeutic interventions in related disorders.
